![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Synairgen Plc | LSE:SNG | London | Ordinary Share | GB00B0381Z20 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.235 | -4.94% | 4.52 | 4.35 | 4.69 | 4.75 | 4.36 | 4.75 | 212,429 | 16:35:15 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 0 | -17.65M | -0.0876 | -0.50 | 9.58M |
Date | Subject | Author | Discuss |
---|---|---|---|
30/4/2020 12:13 | Good progress on trial with 75% on initial tranche already treated | ![]() blueblood | |
30/4/2020 12:12 | Gold as we knew | nick9013 | |
30/4/2020 12:11 | news hitting the tape gents...what we already knew however | ![]() markinvestor | |
30/4/2020 12:10 | *SYNAIRGEN GOT APPROVALS TO EXTEND SARS-COV-2 SG016 TRIAL | ![]() markinvestor | |
30/4/2020 11:57 | A real problem we have are tests aren't robust and giving false results. Spoke to friend who works on front line and says he's had a patient with clear C19 symptoms that didn't test positive until 4th swab! | ![]() blueblood | |
30/4/2020 11:54 | Home treatment combined with an easy quick test will be the future, especially care homes which can keep a stock on standby. Avacta's test out in June (?) is a saliva, spit on a stick, lateral flow test. Low cost and results in 10 minutes. | ![]() pdt | |
30/4/2020 11:38 | I think it is showing some success and the earlier treatment is started the better, hence the home trial. That’s just my layman’s view but if true shows we have a real winner here. | ![]() rafboy | |
30/4/2020 11:36 | Synairgen is discussed in the podcast - very brief mention from 36:34 The fund manager also discusses in the podcast how she has invested in Synairgen (SNG:AIM) and other stocks looking to treat coronavirus or help pharma companies to find a vaccine. | ![]() makendon | |
30/4/2020 11:31 | Apologies for re-posting - I missed news of the amendment yesterday - This is a significant development in my opinion - The trial must be yielding positive results | ![]() hotmark | |
30/4/2020 11:31 | Thanks for posting the info Hotmark. High expectation of a serious winner here ! | ![]() westmoreland lad | |
30/4/2020 11:30 | Thursdays are great. I suppose that is why I purchased so many on Monday and Tuesday hoping that my theory of a blue Thursday would happen | ![]() vitec | |
30/4/2020 11:29 | Great trading share with extras added each time. | ![]() bmnsa | |
30/4/2020 11:29 | I assume it's people buying that were not aware of the amendment. | ![]() markinvestor | |
30/4/2020 11:28 | Up again:)) | ![]() bmnsa | |
30/4/2020 11:28 | It's going so well today we may even see Likya! :-) | ![]() dovey21 | |
30/4/2020 11:26 | Should see a move back to 60@s on the bid shortly, great reversal | ![]() tburns | |
30/4/2020 11:25 | Up she rises. | ![]() bmnsa | |
30/4/2020 11:23 | Yes thanks. It has been discussed on this thread since yesterday. | ![]() markinvestor | |
30/4/2020 11:20 | Expecting an RNS later today - Good luck to all LTHs | ![]() hotmark | |
30/4/2020 11:17 | A significant amendment to the trial was approved yesterday | ![]() hotmark | |
30/4/2020 11:11 | @wilkinson_team · 2h Professor Tom Wilkinson will be the clinical academic lead for ACCORD, a new collaborative national programme aiming to accelerate drug development processes from years to months to get new #COVID19 treatments into national trials | ![]() markinvestor | |
30/4/2020 11:01 | Nobbygnome 29 Apr '20 - 10:51 - 5460 of 5590 AA GILL once compared a steak he ate in the Elephant in London as " tough as old boots" he explained that whilst he felt bad for doing so he couldn't think of anything finer by way of expressive narrative... "Tarts draws" You are forgiven as its certainly apt though Brownian Motion could equally describe some of the random share movements in these volatile markets. | ![]() ant15 | |
30/4/2020 11:00 | Exactly, but I suspect it's release created a short lived bounce. | ![]() gbh2 | |
30/4/2020 11:00 | They are hoping for some results around mid June so we should know ourselves before then. | ![]() cambradjones |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions